Skip to content

Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy

Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy and Inmediate Reconstruction With Prepectoral Implant. Prospective Study for the Evaluation of the Feasibility and Safety of the Technique, Quality of Life and Cosmetic Results

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06823414
Enrollment
126
Registered
2025-02-12
Start date
2025-02-01
Completion date
2034-04-01
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer Non-invasive Breast Cancer, High Risk Breast Carcinoma

Brief summary

Non-inferiority study of video-assisted (endoscopic or robotic) skin- and nipple-sparing mastectomy compared to open mastectomy. The feasibility of the technique, oncological safety and cosmetic results will be studied.

Interventions

OTHERVideo assisted mastectomy

Nipple Skin sparing mastectomy assisted by endoscopic or robotic

Sponsors

Alejandra García-Novoa
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women who require a mastectomy and who do not require skin reduction or resection are included. Women with both breast cancer and those at high risk for breast cancer are included.

Exclusion criteria

* Sarcomas of the breast. * Benign breast tumors. * Prepectoral reconstruction with expansion. * Impossibility to preserve the skin. * Need for reduction pattern * Inability to perform an MRI during follow-up (obesity, claustrophobia, etc.). * Inability to complete the BREAST-Q™ questionnaire due to the patient's cognitive alterations. * Refusal of the patient to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Implant LossFirst year after surgerySafety of the reconstruction technique, calculated by the number of implants lost

Secondary

MeasureTime frameDescription
local relapsefirst 5 yearsevaluate oncological safety in terms of local relapses
Glandular residual tissuefirst yearResidual glandular tissue after endoscopic mastectomy identified by magnetic resonance imaging one year after the intervention
Suvival5 yearsOverall survival

Countries

Spain

Contacts

Primary ContactAlejandra García Novoa, PhD MD
maria.alejandra.garcia.novoa@sergas.es981178000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026